DoseGear research brief
Synthetic octapeptide functioning as topical Botox alternative, targeting dynamic facial wrinkles through SNARE complex modulation. Up to 63% wrinkle depth reduction demonstrated clinically.
Acetyl Octapeptide-3
Acetyl Octapeptide-3 | Anti-Wrinkle & Expression Line Peptide
DoseGear research brief
Synthetic octapeptide functioning as topical Botox alternative, targeting dynamic facial wrinkles through SNARE complex modulation. Up to 63% wrinkle depth reduction demonstrated clinically.
Mimics SNAP-25 protein N-terminal, competitively inhibits SNARE complex formation, reduces acetylcholine release at neuromuscular junctions.
Compound background
Study windows describe what researchers measured, not when an individual should expect a result.
Synthetic cosmetic octapeptide related to acetyl-hexapeptide research.
Expression-line research through proposed SNARE-complex interference; delivery and target engagement require qualification.
Not reported with secure SNAP-8-specific attribution; a cited 30-day Argireline result is not a SNAP-8 result.
Reference data
Not personalized dosing instructions
Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.
The Anti-Wrinkle Efficacy of Argireline, a Synthetic Hexapeptide, in Chinese Subjects: A Randomized, Placebo-Controlled Study
A Synthetic Hexapeptide (Argireline) with Antiwrinkle Activity
Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy
Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects
This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.